Concentration Details

Metabolite
HMDB0004362 (4-Hydroxynonenal)
Biospecimen
Blood
Status
Detected and Quantified
Data source
Referenced
Concentration
2650.0 +/- 140.0 uM
Age
Adult (>18 years old)
Sex
Both
Condition
Peripheral arterial disease
References
    1. Signorelli SS, Fatuzzo P, Rapisarda F, Neri S, Ferrante M, Oliveri Conti G, Fallico R, Di Pino L, Pennisi G, Celotta G, Massimiliano A: A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis. Drugs Aging. 2006;23(3):263-70. [PubMed:16608381 ]